NPR lays out the upcoming docket for the Supreme Court. There’s a theme in the cases highlighted: the executive branch should be able to do whatever it wants. Let’s look at the FDA case as an example. You can’t sell a drug in the US unless you get federal approval from the FDA. I and others have pointed out many times that the process is arbitrary and harmful, especially since consumers are led to believe that FDA-approved drugs are de facto safe. On this point, I have to agree with Wyeth Pharmaceuticals’ lawyers: that the FDA approves the drug and … Continue reading Supreme Court on the FDA